# Plan Validation: Task 2 - Prescription Data Models and Validation Logic

**Generated**: 2026-02-13
**Validator**: Claude Code Validation Agent
**Plan File**: `/Users/stephenfeather/Development/Pharmacokinetics-Grapher/thoughts/shared/plans/task-2-prescription-models.md`

---

## Overall Status: **APPROVED WITH RECOMMENDATIONS**

The implementation plan for Task 2 is **sound and ready for implementation**. All core architectural decisions are well-reasoned and align with TypeScript/Vue 3 best practices for 2025-2026. No blocking issues were found. Three recommendations are offered to strengthen the plan further.

---

## Precedent Check

**Verdict**: ✓ PASS (partial)

**Findings**:
- No prior validation of prescription data models found in the memory system (greenfield implementation)
- Found relevant prior learning: "Pharmacy inserts provide parameter ranges (not exact values)" - this directly supports the plan's validation philosophy of "permissive-with-warnings"
- Prior sessions identified that TypeScript strict mode with proper type inference is the standard for this project
- No conflicting precedent from past validation implementations

**Conclusion**: Clean precedent - no conflicts with past approaches.

---

## Tech Choices Validated

### 1. **ValidationResult with Separate errors[] and warnings[] Arrays**

**Purpose**: Distinguish validation failures (user cannot proceed) from cautions (user should be informed but can proceed).

**Status**: ✓ VALID

**Findings**:
- This pattern aligns with CLAUDE.md specification which explicitly requires warnings for `uptake >= halfLife`
- Vue 3 form validation best practices support error/warning separation for differential UI display (red vs yellow)
- See: [Vue JS 3 Composition API → Registration Form Validation](https://softauthor.com/vue-js-3-composition-api-reusable-scalable-form-validation/)
- The plan correctly implements this as `valid = (errors.length === 0)` regardless of warnings

**Recommendation**: Keep as-is. This is the correct pattern.

---

### 2. **Hand-Rolled Validation vs. Zod/Valibot**

**Purpose**: Implement validation without a third-party library.

**Status**: ⚠ VALID BUT NEEDS DISCUSSION

**Research Findings**:
- Zod is the dominant validation library for TypeScript in 2025 (provides runtime + compile-time safety)
- For **untrusted external data** (APIs, user input), Zod/Valibot are recommended by [TypeScript vs Zod: Clearing up validation confusion](https://blog.logrocket.com/when-use-zod-typescript-both-developers-guide/)
- For **internal/trusted data**, hand-rolled validation is acceptable
- Vue 3 integrates well with Zod via `@vee-validate/zod` package

**Analysis**:
- Prescription data in this project is **user-entered** (untrusted external data), suggesting Zod would be modern best practice
- However, plan is defensible because:
  1. Validation logic is simple and domain-specific (not generic)
  2. Adding Zod increases dependency count and bundle size (~4KB gzip)
  3. Hand-rolled approach makes the validation rules readable and self-documenting
  4. Project is educational/visualization focused (not production medical data)

**Recommendation**: The hand-rolled approach is acceptable for MVP. Consider Zod in Phase 2 if validation grows in complexity or if the project shifts toward production use. Document this decision in the code comments.

---

### 3. **String Union Type vs. TypeScript Enum for FrequencyLabel**

**Purpose**: Represent the 8 allowed dosing frequencies.

**Status**: ✓ VALID

**Findings**:
- String unions are idiomatic modern TypeScript (confirmed by [Mastering TypeScript Best Practices to Follow in 2026](https://www.bacancytechnology.com/blog/typescript-best-practices))
- Enums have known issues with `isolatedModules` and don't tree-shake well
- Plan correctly uses `type FrequencyLabel = 'once' | 'bid' | ...` pattern

**Recommendation**: Keep as-is. This is the correct pattern for 2025+.

---

### 4. **Record<FrequencyLabel, number | null> Type for FREQUENCY_MAP**

**Purpose**: Ensure FREQUENCY_MAP stays synchronized with FrequencyLabel type.

**Status**: ✓ VALID

**Findings**:
- TypeScript will enforce that all FrequencyLabel values have corresponding keys in the map
- If a new frequency is added to the union, TypeScript will error until the map is updated
- This is a best practice for sealed/exhaustive maps

**Recommendation**: Keep as-is. The plan correctly documents this safety mechanism (Risk Mitigation 1).

---

### 5. **KA_KE_TOLERANCE = 0.001 Constant Export**

**Purpose**: Threshold for detecting uptake ≈ halfLife (ka ≈ ke), used in both validation and calculations.

**Status**: ✓ VALID AND RECOMMENDED

**Findings**:
- The plan correctly identifies that this threshold needs to be shared between validation (warning) and calculations (formula switching)
- Exporting this constant prevents divergence between the two uses
- 0.001 is a reasonable absolute tolerance for the magnitude of ka/ke values (both in range [0.003, 6.93])

**Recommendation**: Keep as-is. The plan correctly documents this in Phase 5.

---

### 6. **Time Validation Regex: /^([01]\d|2[0-3]):([0-5]\d)$/**

**Purpose**: Validate 24-hour HH:MM format without seconds.

**Status**: ✓ VALID

**Findings**:
- Regex correctly validates:
  - Hours 00-23 (rejects 24-25, allows 00-09 with leading zero)
  - Minutes 00-59
  - Rejects single-digit hours (e.g., "9:00" must be "09:00")
  - Rejects seconds entirely
- Test coverage in plan includes `00:00`, `23:59`, and invalid formats

**Recommendation**: Keep as-is. This is correct.

---

### 7. **Cross-Field Validation Only When Both Fields Are Valid**

**Purpose**: Avoid NaN/Infinity issues in ka/ke computation.

**Status**: ✓ VALID

**Findings**:
- Plan correctly states: "Only compute warnings if both uptake and halfLife passed their individual validations"
- This prevents computing ka/ke when values are NaN or out-of-range
- Proper defensive programming for edge cases

**Recommendation**: Keep as-is. The plan implements this correctly (Phase 4 Detail, Risk Mitigation 3).

---

### 8. **Whitespace-Only Names Treated as Empty**

**Purpose**: Prevent invisible/meaningless entries like "   " in prescription list.

**Status**: ✓ VALID

**Findings**:
- Plan correctly trims before checking length
- This is standard UX practice for form validation

**Recommendation**: Keep as-is.

---

### 9. **Accumulate All Errors (No Short-Circuit)**

**Purpose**: Show user all validation problems at once, not one at a time.

**Status**: ✓ VALID

**Findings**:
- Better UX than sequential error checking (user sees all problems, not just first)
- Simpler implementation (no early returns)
- Aligns with modern form validation UX practices

**Recommendation**: Keep as-is. This is correct.

---

### 10. **Separate Fixtures File**

**Purpose**: Reusable test prescriptions across Task 2 and Task 3 (calculations).

**Status**: ✓ VALID

**Findings**:
- Plan correctly avoids importing from spec files (which some test runners handle poorly)
- Fixtures are clearly reusable
- Fixtures exported as named constants (good for IDE autocomplete)

**Recommendation**: Keep as-is.

---

### 11. **VALIDATION_RULES and FREQUENCY_MAP Exported as Public**

**Purpose**: Needed by Task 3 (calculations), Task 4 (storage), and Task 5+ (UI).

**Status**: ✓ VALID

**Findings**:
- Plan correctly identifies all downstream consumers
- Exports are properly documented in Integration Points section

**Recommendation**: Keep as-is.

---

### 12. **Barrel Export Pattern (using export type vs export)**

**Purpose**: Distinguish runtime values from type-only exports.

**Status**: ✓ VALID

**Findings**:
- Using `export type` for interfaces/type aliases is modern TypeScript best practice
- Using `export` for runtime values (constants/functions) is idiomatic
- This pattern enables `isolatedModules` compatibility and tree-shaking

**Recommendation**: Keep as-is. The plan implements this correctly (Phase 5).

---

## Summary

### Validated (Safe to Proceed): ✓

- ValidationResult with errors/warnings separation
- String union type for FrequencyLabel
- Record<FrequencyLabel, number | null> pattern
- KA_KE_TOLERANCE constant
- HH:MM time validation regex
- Cross-field validation guard (only when both fields valid)
- Whitespace-trimming for names
- Error accumulation (no short-circuit)
- Separate fixtures file
- Public exports for downstream tasks
- Barrel export pattern with `export type`

### Needs Discussion (Acceptable but Worth Noting):

- **Hand-rolled validation vs. Zod**: Defensible for MVP but consider Zod in Phase 2 for production use or if validation complexity grows

### Must Change:

*None found. All core decisions are sound.*

---

## Detailed Recommendations

### Recommendation 1: Document Validation Library Decision

**What**: Add a comment block to `prescription.ts` explaining the hand-rolled validation choice.

**Why**: Future developers may wonder why Zod wasn't used. A clear explanation prevents unnecessary refactoring requests.

**Suggested comment**:
```typescript
/**
 * VALIDATION APPROACH:
 *
 * This module uses hand-rolled validation rather than a library like Zod because:
 * 1. Validation logic is simple and domain-specific (not generic)
 * 2. Adds no external dependencies (smaller bundle)
 * 3. Validation rules are self-documenting and directly readable
 *
 * If validation complexity grows or the project moves to production use,
 * consider migrating to Zod for compile-time type safety + runtime validation.
 * See: https://blog.logrocket.com/when-use-zod-typescript-both-developers-guide/
 */
```

---

### Recommendation 2: Add TypeScript Strict Mode Compatibility Note

**What**: Document that the implementation assumes `strict: true` in tsconfig.

**Why**: Strictest TypeScript settings are enabled in this project. Validation should leverage that.

**Suggested note** (add to Phase 1 or integration section):
```
Note: This implementation assumes tsconfig.json has strict mode enabled
(strict: true, noImplicitAny: true, strictNullChecks: true).
All fields are properly typed to ensure no 'any' types escape type checking.
```

---

### Recommendation 3: Validate Floating-Point Edge Case in Tests

**What**: Add an explicit test for values very close to the boundary thresholds.

**Why**: Floating-point comparisons can be tricky. The plan covers `0.1` and `0.09`, which is good, but consider:

**Suggested test additions**:
```typescript
// Test: Very close to boundary (floating-point precision)
- PASS: halfLife = 0.10000001 -> valid
- FAIL: halfLife = 0.09999999 -> error (just below 0.1)
- PASS: dose = 0.0010000001 -> valid
- FAIL: dose = 0.0009999999 -> error
```

This ensures the comparison operator (`>=` vs `>`) is correct and floating-point rounding doesn't cause unexpected rejections.

---

### Recommendation 4: Consider Future Extensibility for VALIDATION_RULES

**What**: Document how to extend VALIDATION_RULES if new fields are added.

**Why**: The plan correctly centralizes all ranges, but future developers should understand the pattern.

**Suggested documentation**:
```typescript
/**
 * VALIDATION_RULES centralize all field constraints.
 *
 * To add a new field:
 * 1. Add field to Prescription interface
 * 2. Add field to VALIDATION_RULES with appropriate constraints
 * 3. Add validator function for the field
 * 4. Add tests for the field
 * 5. Update main validatePrescription() to call the new validator
 *
 * This pattern ensures all validation constraints are in one place.
 */
```

---

## Pharmacokinetic Correctness Check

**Status**: ✓ VERIFIED

Cross-referenced the plan against CLAUDE.md pharmacokinetic specifications:

- ✓ Uptake/halfLife edge case handling matches spec: "permissive-with-warnings" philosophy
- ✓ Ka ≈ ke threshold (0.001) matches CLAUDE.md: "|ka - ke| < 0.001" fallback condition
- ✓ Time ranges [0.1, 240] for halfLife match CLAUDE.md ranges
- ✓ All other ranges (dose, peak, uptake) match CLAUDE.md specification
- ✓ Comment about `peak` being informational-only (not used in calculations) is documented correctly

**Conclusion**: Validation ranges and logic are pharmacokinetically correct.

---

## Integration Verification

**Status**: ✓ VERIFIED

Checked against downstream task requirements:

| Task | Integration Point | Plan Handles? |
|------|------------------|---------------|
| Task 3 (Calculations) | Import `Prescription`, `TimeSeriesPoint`, `FREQUENCY_MAP`, `KA_KE_TOLERANCE` | ✓ All exported |
| Task 3 (Calculations) | Use ka ≈ ke threshold for formula switching | ✓ Exported constant |
| Task 4 (Storage) | Serialize `Prescription` to JSON | ✓ No special handling needed (JSON-compatible) |
| Task 5+ (UI) | Import `FrequencyLabel`, `FREQUENCY_MAP`, `VALIDATION_RULES` | ✓ All exported |
| Task 5+ (UI) | Display min/max hints from `VALIDATION_RULES` | ✓ Constant exported |
| Task 5+ (UI) | Show warnings separately from errors | ✓ Separate arrays |

**Conclusion**: Plan integrates cleanly with all downstream tasks (3-9). No architectural conflicts detected.

---

## Code Quality Checklist

**Status**: ✓ PASS

- ✓ TypeScript strict mode compatible (all types explicit, no `any`)
- ✓ ESLint/Prettier compatible (no syntax violations)
- ✓ Test framework (Vitest) compatible (uses standard describe/it/expect pattern)
- ✓ Vue 3 + Composition API compatible (uses pure functions, no framework coupling)
- ✓ Path alias compatible (uses `@/` correctly in barrel export)

---

## Risk Assessment

| Risk | Mitigation in Plan | Severity |
|------|-------------------|----------|
| FREQUENCY_MAP divergence from FrequencyLabel | `Record<FrequencyLabel, number \| null>` type ensures sync | Low |
| Time regex too strict | Regex tested for `00:00`, `23:59`, common invalid formats | Low |
| Cross-field validation NaN | Only runs when both fields are valid | Low |
| Floating-point ka/ke comparison | Uses absolute tolerance 0.001 (appropriate magnitude) | Low |
| Future validation complexity | Hand-rolled approach; Zod migration documented | Medium |

**Overall Risk Level**: LOW

All identified risks have mitigations in place. No blocking issues.

---

## Best Practices Alignment

**TypeScript 2025-2026 Best Practices**:
- ✓ Strict mode enabled and leveraged
- ✓ String unions over enums
- ✓ Proper use of type inference
- ✓ Export type vs export distinction
- ✓ No `any` types

**Vue 3 Composition API Best Practices**:
- ✓ Pure functions (not component-coupled)
- ✓ Reusable fixtures for tests
- ✓ Proper use of TypeScript generics (if used)

**Form Validation Best Practices**:
- ✓ Separate errors from warnings
- ✓ Accumulate all errors (better UX)
- ✓ Clear error messages
- ✓ Centralized rules (VALIDATION_RULES)

**Pharmacokinetics Best Practices**:
- ✓ Permissive-with-warnings approach for atypical parameters
- ✓ Ranges justified by pharmacy insert specifications
- ✓ Edge case handling (ka ≈ ke) documented

---

## Testing Completeness Assessment

**Estimated Test Coverage**: ~50 test cases across 15 test categories

**Coverage Assessment**:

| Category | Test Count | Adequacy |
|----------|-----------|----------|
| Valid prescriptions | 8 | ✓ Good |
| Name validation | 4 | ✓ Adequate |
| Dose validation | 6 | ✓ Good |
| Frequency validation | 2 | ⚠ Could add parametrized test for all 8 |
| Times validation | 12 | ✓ Excellent |
| halfLife validation | 6 | ✓ Good |
| Peak validation | 5 | ✓ Adequate |
| Uptake validation | 5 | ✓ Adequate |
| MetaboliteLife validation | 5 | ✓ Adequate |
| Cross-field warnings | 4 | ✓ Adequate |
| Multiple errors | 1 | ⚠ Could expand |
| Edge cases | 4 | ✓ Adequate |
| Reference fixtures | 6 | ✓ Good |

**Total**: ~68 test cases planned (exceeds 50 estimate)

**Recommendation**: Test count is comprehensive. Consider parameterized testing for frequency validation (to test all 8 types in one test) to reduce duplication.

---

## Approval Decision

**STATUS**: ✅ **APPROVED**

### Approval Conditions:

1. ✓ All core architectural decisions are sound
2. ✓ Type safety is comprehensive (strict mode compliant)
3. ✓ Validation logic matches pharmacokinetic specification
4. ✓ Integration with downstream tasks is clean
5. ✓ Test coverage is adequate (~68 test cases, 100% branch coverage target)
6. ✓ No blocking issues found

### Action Items (Optional Enhancements):

- [ ] Add validation library decision comment (Recommendation 1)
- [ ] Document strict mode assumption (Recommendation 2)
- [ ] Add floating-point edge case tests (Recommendation 3)
- [ ] Document VALIDATION_RULES extension pattern (Recommendation 4)

### Estimated Implementation Effort:

**Time**: 1-2 hours (as stated in plan)
**Risk**: Low
**Dependencies**: None (greenfield implementation)

---

## Final Assessment

This is a **well-planned, thorough, and defensible implementation**. The author has:

1. ✓ Analyzed the existing codebase carefully
2. ✓ Identified all downstream consumers
3. ✓ Documented architectural decisions with rationale
4. ✓ Planned comprehensive test coverage
5. ✓ Considered edge cases and pharmacokinetic correctness
6. ✓ Followed modern TypeScript (2025) best practices

**The plan is ready for implementation. No blocking issues were found.**

The only recommended enhancements are documentation improvements and consideration of Zod for future phases if validation complexity grows.

---

## Sources

- [Mastering TypeScript Best Practices to Follow in 2026](https://www.bacancytechnology.com/blog/typescript-best-practices)
- [TypeScript vs Zod: Clearing up validation confusion - LogRocket Blog](https://blog.logrocket.com/when-use-zod-typescript-both-developers-guide/)
- [Best Practices for Using TypeScript in 2025: A Guide for Experienced Developers](https://medium.com/@nikhithsomasani/best-practices-for-using-typescript-in-2025-a-guide-for-experienced-developers-4fca1cfdf052)
- [Vue JS 3 Composition API → Registration Form Validation [2025]](https://softauthor.com/vue-js-3-composition-api-reusable-scalable-form-validation/)
- [Top 6 Validation libraries for JavaScript in 2025 - Devmystify](https://devmystify.com/blog/top-6-validation-libraries-for-javascript-in-2025)
- [Intro to Vuelidate](https://learnvue.co/articles/intro-to-vuelidate)
- [GitHub - colinhacks/zod: TypeScript-first schema validation with static type inference](https://github.com/colinhacks/zod)

---

**Validation completed**: 2026-02-13
**Validated by**: Claude Code Validation Agent
**Confidence level**: High
**Ready to implement**: YES
